Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Doug Altman, Professor of Statistics in Medicine at NDORMS and Director of the Centre for Statistics in Medicine (CSM), has been awarded an honorary doctorate from the University of Utrecht.

Doug Altman, Professor of Statistics in Medicine at NDORMS and Director of the Centre for Statistics in Medicine (CSM), has been awarded an honorary doctorate from the University of Utrecht.

An advocate for transparency in scientific research, Professor Altman is one of the most influential and cited researchers in the biomedical sciences. His work and achievements have a wide reach across the medical sciences and reflect his dedication to increasing the methodological rigour of medical research and the transparency of medical research publications.

Speaking of his award, Professor Altman said: “Medical research is done to increase knowledge about how to treat or prevent disease. Use of inappropriate methods, selective publication of results, and failure to report exactly what was done and what the findings were, all devalue the evidence which clinicians use to help determine the best treatments for all of us.” He added: “All medical researchers have a responsibility to the participants in that research, to those who fund it, and to society at large to conduct research to a high standard and to publish the findings in a complete and transparent form. In essence my work, and those of my research group in Oxford and many of my collaborators, has all been aimed at trying to help researchers meet those goals. This award indicates that I have had some success; I am deeply honoured to receive an honorary degree from the prestigious University of Utrecht.”

According to the University of Utrecht, Professor Altman’s work on transparency is consistent with recent social movements in which science is critically considered and questioned, and emphasis is placed on the social responsibility of researchers and research institutes.

Professor Andrew Carr, Head of NDORMS said: “Doug Altman’s contributions to medical science are quite simply outstanding. Throughout his career he has promoted the transparent and high quality reporting of evidence and through this approach has improved the care of patients. This award is a wonderful recognition of his work.”

Professor Altman’s contributions to medicine, in particular cancer research, and medical statistics have been immense and in 1997 he received the Bradford Hill Medal by the Royal Statistical Society.

Having a long-standing interest in the reporting of medical research, he is an executive member of several groups that have published reporting guidelines, including CONSORT for randomised trials, PRISMA for systematic reviews, STROBE for epidemiological studies, and REMARK for tumour marker prognostic studies. He is co-founder of the EQUATOR Network, which provides essential resources for writing and publishing health research.

In addition to his work on transparency in research, Professor Altman is also known worldwide for the ‘Bland-Altman plot’, a very widely cited method to compare two methods of clinical measurements. 

 

*Update: see the video of the ceremony here (about 25 minutes in)*

Similar stories

New centre aims to help companies conduct more efficient trials

Botnar Main Trials

A new clinical therapeutics centre has been set up by the University of Oxford to help life sciences companies identify interventions that have the greatest potential to deliver patient benefit, and so bring down the cost of early phase clinical trials.

Cognitive–behavioural therapy consistently improves quality of life

Main Rehabilitation and self-management Research

A meta-review of the available research into cognitive behavioural therapy reveals it consistently improves health-related quality of life across different medical conditions and demographic populations.

Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders

Main Research

The University of Oxford has entered into a strategic collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Versus Arthritis Foundation Fellowship awarded to Dr Kristina Zec

Awards Main

Dr Kristina Zec has been awarded a Versus Arthritis Foundation Fellowship to investigate the role of products of lipid oxidation produced by synovial macrophages in triggering articular inflammation.

Study reveals the safety of bisphosphonates in chronic kidney disease

Main

The results of an observational study published in JMBR and funded by the Health Technology Assessment Programme shows that bisphosphonate use is associated with a greater risk of chronic kidney disease progression.

WHiTE Four trial results published

Hip Main OCTRU Orthopaedics and trauma Research

The results of the WHiTE Four clinical trial for the treatment of fragility hip fractures have been published in The Bone and Joint Journal.